While the new drug reduced hematoma expansion compared with usual care, it was also associated with an increase in thrombotic events in the ANNEXa-I study.
An exploratory analysis suggests a transfusion-transmissible agent associated with brain amyloidosis may be associated with some types of spontaneous intracerebral hemorrhage.
Intensive blood pressure management worsens outcomes and should not be pursued in stroke patients successfully recanalized with intra-arterial thrombectomy, results of the OPTIMAL-BP trial show.